tm logo
Trademark Search
AMLYPAVE

View On IC.GC.CA

AMLYPAVE
REGISTERED

on 04 Oct 2024

Last Applicant/ Owned by

ALEXION PHARMACEUTICALS INC.

121 Seaport BoulevardBoston MA 02210

US

Serial Number

2183974 filed on 07th Apr 2022

Registration Number

TMA1261228 registered on 04th Oct 2024

Registration expiry Date

07th Apr 2032

Correspondent Address

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa

ONTARIO

CA

K1P5Y6

AMLYPAVE

Trademark usage description

pharmaceutical preparations for the treatment of autoimmune diseases and disorders, protein aggregation-related diseases and disorders, namely, diseas Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of autoimmune diseases and disorders, protein aggregation-related diseases and disorders, namely, diseases caused by protein deposition, abnormal proteins, production and aggregation-related diseases and disorders, namely, amyloidosis, and neurodegenerative diseases and disorders.

Classification kind code

11

Mark Details

Serial Number

2183974

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 08th Nov 2023		Agent Changed
Submitted for opposition 22
on 22nd Aug 2023		Search Recorded
Submitted for opposition 20
on 22nd Aug 2023		Examiner's First Report
Submitted for opposition 223
on 22nd Aug 2023		Total Provisional Refusal
Submitted for opposition 256
on 06th Mar 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 05th May 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 05th May 2022		Formalized
Submitted for opposition 1
on 05th May 2022		Created
Submitted for opposition 228
on 07th Apr 2022		International Registration
Submitted for opposition 30
on 07th Apr 2022		Filed